Electrochemical biosensors are promoting point-of-care and wearable instrumentation due to their high versatility in measuring human metabolites. There is a considerable number of biological compounds that can be detected and measured through voltammetry based techniques. Voltmmetry some times requires peak identification and quantification that are non-trivial to be efficiently implemented by automatic instrumentation. To overcome the complexity of automatic peak estimation, we propose here an instrumentation circuit for edge-computing in pharmacology relying on an entirely novel measurement method via TotalCharge Detection in Cyclic voltammetry (TCDC). Namely, our TCDC method innovatively applies the coulometry measurement to the well-established voltammetry procedure. The proposed instrumentation accumulates the total charge exchanged in the faradaic process, exploiting a Nagaraj integrator as charge suppressor to fit the application-specific constraints. The work shows accurate simulations of the TCDC circuit on a set of experimental measures, acquired on paracetamol as benchmark drug. The proposed measurement technique and the developed circuit are compared to the peak detection method usually adopted in literature. The results demonstrate that the proposed system is a perfect trade-off between the doubled limit-of-detection and a tenfold reduction in measurement errors. At the same time, we eliminate any need for data oversampling and processing, promoting the TCDC as an efficient new measurement method for point-of-care and wearable monitoring of biological compounds.